Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,149,660
  • Shares Outstanding, K 202,405
  • Annual Sales, $ 132,300 K
  • Annual Income, $ -44,370 K
  • 60-Month Beta 1.33
  • Price/Sales 8.61
  • Price/Cash Flow N/A
  • Price/Book 17.79
Trade IMGN with:

Options Overview

Details
  • Implied Volatility 105.19%
  • Historical Volatility 44.03%
  • IV Percentile 62%
  • IV Rank 50.90%
  • IV High 144.09% on 09/23/20
  • IV Low 64.87% on 12/18/20
  • Put/Call Vol Ratio 0.05
  • Today's Volume 109
  • Volume Avg (30-Day) 1,084
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 22,196
  • Open Int (30-Day) 14,721

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.19
  • Number of Estimates 7
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.97 +14.29%
on 08/20/21
6.30 -9.84%
on 09/02/21
+0.48 (+9.23%)
since 08/16/21
3-Month
4.97 +14.29%
on 08/20/21
7.11 -20.08%
on 06/28/21
-1.09 (-16.10%)
since 06/16/21
52-Week
3.43 +65.60%
on 09/24/20
10.88 -47.79%
on 02/12/21
+1.55 (+37.53%)
since 09/16/20

Most Recent Stories

More News
Analysts Make the Case for Small-Cap Biotech Stocks This Fall (INMB, DVAX, SAVA, ICPT, IMGN, ATRX)

IBB : 172.51 (+0.41%)
MRNA : 440.00 (-0.15%)
INMB : 18.07 (+3.49%)
ATRX : 0.1400 (-20.09%)
SAVA : 43.93 (-0.05%)
DVAX : 14.45 (+0.07%)
ICPT : 15.41 (+2.19%)
IMGN : 5.68 (+0.89%)
Sutro (STRO) Ovarian Cancer Drug Gets FDA's Fast Track Tag

Sutro's (STRO) investigational antibody-drug conjugate therapy, STRO-002, gets Fast Track designation from the FDA for advanced ovarian cancer.

BMY : 61.36 (+0.21%)
MRNA : 440.00 (-0.15%)
IMGN : 5.68 (+0.89%)
STRO : 19.98 (-0.05%)
ImmunoGen is Now Oversold (IMGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

IMGN : 5.68 (+0.89%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on July 30, 2021 the compensation committee of the Company's...

IMGN : 5.68 (+0.89%)
ImmunoGen (IMGN) Q2 Loss Narrower Than Expected, Revenues Lag

ImmunoGen (IMGN) reports narrower-than-expected loss but misses revenue estimates.

RHHBY : 46.8200 (-0.09%)
BMY : 61.36 (+0.21%)
MRK : 72.12 (+0.21%)
IMGN : 5.68 (+0.89%)
ImmunoGen (IMGN) Reports Q2 Loss, Misses Revenue Estimates

ImmunoGen (IMGN) delivered earnings and revenue surprises of 16.67% and -10.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

IMGN : 5.68 (+0.89%)
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results

--Top-line Data from Pivotal SORAYA Trial on Track for Q4 Release

IMGN : 5.68 (+0.89%)
Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for

ImmunoGen (IMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IMGN : 5.68 (+0.89%)
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating Results

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m....

IMGN : 5.68 (+0.89%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on June 30, 2021 the compensation committee of the Company's...

IMGN : 5.68 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended...

See More

Key Turning Points

3rd Resistance Point 6.05
2nd Resistance Point 5.87
1st Resistance Point 5.78
Last Price 5.68
1st Support Level 5.50
2nd Support Level 5.32
3rd Support Level 5.22

See More

52-Week High 10.88
Fibonacci 61.8% 8.03
Fibonacci 50% 7.16
Fibonacci 38.2% 6.28
Last Price 5.68
52-Week Low 3.43

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar